SB590885

B-Raf kinase (BRAF) inhibitor

产品优势

未找到
Inhibit ERK phosphorylation and cell proliferation in cancer cells with SB590885, a potent inhibitor of B-Raf kinase (BRAF; Kd = 300 pM). BRAF is a key component in the extracellular signal-regulated kinase (ERK); a group of mitogen-activated protein kinase (MAPK) pathways (Takle et al. Bioorg Med Chem Lett, 2006), and mutations in the BRAF regulatory domain have been shown to increase kinase activity and maintain tumorigenicity of melanoma and other cancers. SB590885 influences this process by competitively binding the ATP-binding domain of BRAF, which selectively inhibits BRAF kinase activity (King et al. Cancer Res, 2006; Roskoski. Biochem Biophys Res Commun, 2010).

SB590885 has been used for:

CANCER RESEARCH
· Disrupt endolysosomal pathways, resulting in accumulation of acidic vacuole-like vesicles and sensitizing human melanoma cell lines to endoplasmic reticulum stress (Palušová et al. Cancers, 2020).
· Inhibit ERK phosphorylation, cell proliferation, and anchorage-independent growth of human melanoma cell lines and reduce tumor growth in a mouse xenograft model (King et al. Cancer Res, 2006).
DISEASE MODELING
· Induce hypertrophy in rat cardiomyocytes and promote cardiac hypertrophy in vivo in a mouse model (Clerk et al. Biochem J, 2022).
未找到

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Product Name
SB590885
Catalog #
100-1656
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
SB590885
Catalog #
100-1656
Lot #
All
Language
English
未找到
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。